Lupus & Connective Tissue Diseases
Conference Coverage
Think methotrexate for juvenile localized scleroderma
Conference Coverage
Psoriasiform lesions in Kawasaki disease may spell trouble
Key clinical point: Further study will need to determine if treatment, time to diagnosis, or other factors influence the association between...
News
One in six SLE patients readmitted in 30 days
Key clinical point: One in six patients with systemic lupus erythematosus (SLE) was readmitted to the hospital within 30 days of discharge, and...
Conference Coverage
New insights emerge from pediatric chronic cutaneous lupus
Key clinical point: If pediatric chronic cutaneous lupus erythematosus is going to transform into SLE, it generally does so within the first year...
Conference Coverage
Rituximab yielded long-term benefit in lupus nephritis
Key clinical point: Rituximab delivered long-term results for patients with refractory lupus nephritis.Major finding: During a median follow-up...
Conference Coverage
Deaths mar atacicept trial for lupus, but research continues
Key clinical point: Research continues on atacicept for lupus, despite the deaths of two patients taking 150 mg of the drug.Major finding: In a...
Conference Coverage
Trial of sirukumab for lupus nephritis falls flat
Key clinical point: Janssen has discontinued its investigation of sirukumab for lupus nephritis.Major finding: Almost half of those who took...
Conference Coverage
Real-world use supports belimumab clinical trial data
Key clinical point: Belimumab reduced disease activity, improved quality of life, and reduced steroid usage for patients with systemic lupus...
Conference Coverage
Increased risk of heart attack confirmed in Sjögren’s syndrome patients
Key clinical point: The findings support monitoring for coronary artery disease in patients with Sjögren’s syndrome in addition to management and...
Conference Coverage
SLE patients in remission safely stop immunotherapy
Key clinical point: A majority of selected patients with lupus who stop immunosuppressant therapy do not flare within the next 2 years.Major...